» Articles » PMID: 37726354

Cefaclor Causes Vagus Nerve-mediated Depression-like Symptoms with Gut Dysbiosis in Mice

Overview
Journal Sci Rep
Specialty Science
Date 2023 Sep 19
PMID 37726354
Authors
Affiliations
Soon will be listed here.
Abstract

Antibiotics are increasingly recognized as causing neuropsychiatric side effects including depression and anxiety. Alterations in central serotonin and 5-HT receptor expression are implicated in the pathogenesis of anxiety and depression, which are highly comorbid with gastrointestinal disorders. Nevertheless, it is still unclear how antibiotics can cause anxiety and depression. In this study, oral administration of cefaclor, a second-generation cephalosporin antibiotic, induced anxiety- and depression-like behaviors and colitis with gut microbiota alteration in mice. Cefaclor reduced serotonin levels and fluctuated 5-HT receptor mRNA expressions such as Htr1a, Htr1b, and Htr6 in the hippocampus. Vagotomy attenuated the cefaclor-induced anxiety- and depression-like symptoms, while the cefaclor-induced changes in gut bacteria alteration and colitis were not affected. Fluoxetine attenuated cefaclor-induced anxiety- and depression-like behaviors. Furthermore, fluoxetine decreased cefaclor-resistant Enterobacteriaceae and Enterococcaceae. Taken together, our findings suggest that the use of antibiotics, particularly, cefaclor may cause gut dysbiosis-dependent anxiety and depression through the microbiota-gut-blood-brain and microbiota-gut-vagus nerve-brain pathway. Targeting antibiotics-resistant pathogenic bacteria may be a promising therapeutic strategy for the treatment of anxiety and depression.

Citing Articles

The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder.

Jiang Y, Qu Y, Shi L, Ou M, Du Z, Zhou Z Transl Psychiatry. 2024; 14(1):493.

PMID: 39695082 PMC: 11655517. DOI: 10.1038/s41398-024-03208-z.


A bibliometric analysis of autism spectrum disorder signaling pathways research in the past decade.

Lyu K, Li J, Chen M, Li W, Zhang W, Hu M Front Psychiatry. 2024; 15:1304916.

PMID: 38410675 PMC: 10895046. DOI: 10.3389/fpsyt.2024.1304916.

References
1.
Hao W, Wu J, Yuan N, Gong L, Huang J, Ma Q . Xiaoyaosan Improves Antibiotic-Induced Depressive-Like and Anxiety-Like Behavior in Mice Through Modulating the Gut Microbiota and Regulating the NLRP3 Inflammasome in the Colon. Front Pharmacol. 2021; 12:619103. PMC: 8087337. DOI: 10.3389/fphar.2021.619103. View

2.
. Swedish Study Group. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection. Infection. 1991; 19(4):208-15. DOI: 10.1007/BF01644947. View

3.
Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A . Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004; 97(6):1166-77. DOI: 10.1111/j.1365-2672.2004.02409.x. View

4.
Ianiro G, Tilg H, Gasbarrini A . Antibiotics as deep modulators of gut microbiota: between good and evil. Gut. 2016; 65(11):1906-1915. DOI: 10.1136/gutjnl-2016-312297. View

5.
Husain M, Chaudhry I, Husain N, Khoso A, Rahman R, Hamirani M . Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial. J Psychopharmacol. 2017; 31(9):1166-1175. DOI: 10.1177/0269881117724352. View